205 related articles for article (PubMed ID: 34123679)
1. Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event.
Doodnauth AV; Klar M; Mulatu YS; Malik ZR; Patel KH; McFarlane SI
Cureus; 2021 Jun; 13(6):e15465. PubMed ID: 34123679
[TBL] [Abstract][Full Text] [Related]
2. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
3. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review.
Oğuz SH; Ünlütürk U; Aksoy S; Erbas T
Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129
[TBL] [Abstract][Full Text] [Related]
4. Nothing Great Comes Without Its Risks: A Rare Case of Pembrolizumab-Induced Hypophysitis.
Fernando A; Mittal A; Cheema R
JCEM Case Rep; 2024 Jan; 2(1):luad135. PubMed ID: 38116159
[TBL] [Abstract][Full Text] [Related]
5. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report.
Tanaka S; Kushimoto M; Nishizawa T; Takubo M; Mitsuke K; Ikeda J; Fujishiro M; Ogawa K; Tsujino I; Suzuki Y; Abe M
Clin Diabetes Endocrinol; 2020; 6():1. PubMed ID: 31921440
[TBL] [Abstract][Full Text] [Related]
6. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
Thapi S; Leiter A; Galsky M; Gallagher EJ
J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
[TBL] [Abstract][Full Text] [Related]
7. A case of small-cell lung cancer with adrenocorticotropic hormone deficiency induced by nivolumab.
Zhu Y; Wu HH; Wang W
Onco Targets Ther; 2019; 12():2181-2186. PubMed ID: 30988622
[TBL] [Abstract][Full Text] [Related]
8. Pembrolizumab- and ipilimumab-induced diabetic ketoacidosis and isolated adrenocorticotropic hormone deficiency: a case report.
Porntharukchareon T; Tontivuthikul B; Sintawichai N; Srichomkwun P
J Med Case Rep; 2020 Sep; 14(1):171. PubMed ID: 32988414
[TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitors and Associated Pituitary Dysfunctions: A Mini-Review.
Fukuda I
J Nippon Med Sch; 2023 May; 90(2):149-156. PubMed ID: 36823122
[TBL] [Abstract][Full Text] [Related]
10. Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency.
Hanna RM; Selamet U; Bui P; Sun SF; Shenouda O; Nobakht N; Barsoum M; Arman F; Rastogi A
Case Rep Nephrol Dial; 2018; 8(2):171-177. PubMed ID: 30197906
[TBL] [Abstract][Full Text] [Related]
11. Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review.
Hinata Y; Ohara N; Sakurai Y; Koda R; Yoneoka Y; Takada T; Hara N; Nishiyama T
Am J Case Rep; 2021 Jul; 22():e931639. PubMed ID: 34262010
[TBL] [Abstract][Full Text] [Related]
12. Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis.
Balti E; Verhaeghe S; Kruse V; Roels S; Coremans P
Cureus; 2022 Aug; 14(8):e27763. PubMed ID: 36127991
[TBL] [Abstract][Full Text] [Related]
13. Hypophysitis Induced by Sintilimab in the Treatment of Bladder Cancer: A Case Report.
Li R; Jiang B; Zhu Y; Gao L; Zhou Y; Yang S
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):606-610. PubMed ID: 37818555
[TBL] [Abstract][Full Text] [Related]
14. A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma.
Hakami OA; Ioana J; Ahmad S; Tun TK; Sreenan S; McDermott JH
Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30836329
[TBL] [Abstract][Full Text] [Related]
15. An autopsy case study of lymphocytic hypophysitis induced by nivolumab treatment for esophageal malignant melanoma.
Okabe N; Kobayashi T; Furuse J; Fujiwara M; Kamma H
Pathol Int; 2021 Dec; 71(12):831-836. PubMed ID: 34506687
[TBL] [Abstract][Full Text] [Related]
16. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.
Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M
Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791
[TBL] [Abstract][Full Text] [Related]
17. A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer.
Nagai T; Mogami T; Takeda T; Tomiyama N; Yasui T
Urol Case Rep; 2021 Nov; 39():101766. PubMed ID: 34285878
[TBL] [Abstract][Full Text] [Related]
18. Two Cases of Atezolizumab-Induced Hypophysitis.
Kanie K; Iguchi G; Bando H; Fujita Y; Odake Y; Yoshida K; Matsumoto R; Fukuoka H; Ogawa W; Takahashi Y
J Endocr Soc; 2018 Jan; 2(1):91-95. PubMed ID: 29362727
[TBL] [Abstract][Full Text] [Related]
19. Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up.
Levy M; Abeillon J; Dalle S; Assaad S; Borson-Chazot F; Disse E; Raverot G; Cugnet-Anceau C
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33066179
[TBL] [Abstract][Full Text] [Related]
20. A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency.
Sato Y; Tanaka Y; Hino M; Seike M; Gemma A
Respir Med Case Rep; 2019; 26():223-226. PubMed ID: 30740300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]